Kemwell Biopharma has successfully completed a cGMP joint audit by The Federal Agency for Medicines and Health Products, Belgium and the Medical Products Agency (MPA), of its oral solids manufacturing facility in Bangalore, India, receiving a certificate of GMP compliance as a manufacturer, which is valid for three years.   The audit was performed as part of the European Medicines Agency’s (EMA) evaluation of the Marketing Authorization Application for a NCE for a top global pharma company...